- A strong and specific multi-targeted receptor tyrosine kinase inhibitor, Pazopanib is prescribed to treat advanced soft tissue sarcomas and advanced/metastatic renal cell carcinomas.
What conditions does Pazopanib treat?
Pazopanib, containing pazopanib hydrochloride, is used to address advanced soft tissue sarcomas and advanced or metastatic renal cell carcinomas.
How should Pazopanib be taken?
Take Pazopanib tablet orally around the same time daily, without food, either one hour before or two hours after eating. Swallow the 200 mg or 400 mg tablets whole with water, avoiding opening, dissolving, breaking, or chewing them.
What are the common side effects of Pazopanib?
Common side effects include nausea, vomiting, diarrhea, hypertension, rash, fatigue, myelosuppression (like leucopenia, neutropenia, thrombocytopenia, and lymphopenia), taste changes, swelling, hair loss or color changes.
What are the warnings and precautions associated with Pazppanib?
Fatal arterial thrombotic episodes have occurred in certain cases. Patients at higher risk for adverse events should use Pazopanib cautiously. Individuals who’ve had gastrointestinal bleeding or hemoptysis in the last six months should avoid using it. Regular liver function tests are necessary during treatment.
Are there specific considerations for certain individuals taking Pazopanib?
Caution is advised for those at risk of QT interval prolongation. Electrocardiogram and electrolyte monitoring might be recommended. It’s crucial for women capable of pregnancy to avoid getting pregnant while on Pazopanib.